Month: January 2021

As More Deadly Strains Emerge, the Post Pandemic Recovery SPAC Gears up to Finance “Long-Hauler “treatment through proposed merger with Napo EU; Interview with Lisa Conte and Andreea Porcelli

Lisa Conte and Andreea Porcelli were interviewed again this week on Innovators with Jane King regarding long-hauler syndrome in post-COVID-19 recovery patients and Jaguar’s plans to explore the possibility of obtaining conditional marketing authorization in Europe to support development and commercialization of crofelemer for the COVID-related indication. When discussing post-acute COVID-19 long-hauler symptoms during a […]
Read More

Jaguar Health and Sponsor of Proposed Post Pandemic Recovery Equity SPAC to Host Webcast Wednesday, January 27th at 8:30 AM Eastern Time to Provide Updates Regarding the Potential Merger of Napo EU, the Company’s Anticipated Subsidiary in Italy

Andreea Porcelli, CEO of Swiss Growth Forum, will be a co-presenter on the webcast in her separate capacity as a sponsor of the proposed SPAC San Francisco, CA (January 21, 2021): Jaguar Health, Inc. (NASDAQ: JAGX) (“Jaguar” or the “Company”) announced today that the Company and a sponsor of the proposed Post Pandemic Recovery Equity special […]
Read More

Jaguar Health Provides Replay Link & High-level Overview of January 14th Investor Webcast

San Francisco, CA (January 15, 2021): Jaguar Health, Inc. (NASDAQ: JAGX) (“Jaguar” or the “Company”) today provided the replay link for the Company’s January 14, 2021 investor webcast and a recap of the key points from the presentation.   To access the audio recording and slides from the webcast, click here.   “Due to the unprecedented volume […]
Read More

Subscribe to our newsletter

Sign up to receive latest news, updates, promotions, and special offers delivered directly to your inbox.
No, thanks